InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Scott Bizily. Director active across 1 company, notably 4D Molecular Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. History available since 23 June 2026. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations